Robert Hauptman MD • Alan Kaplan MD

107 Pages·2013·5.24 MB·English

by  Rob Hauptman

Managing CNCP in
High Risk Patients:�
Workshop

• 
Robert Hauptman MD

• 
Alan Kaplan MD
Faculty/Presenter
Disclosure

• 
Faculty: Alan Kaplan MD CCFP(EM) FCFP

• 
Family Physician Richmond Hill

• 
Hospitalist, Brampton Civic Hospital

• 
Pain consultant, Richmond Hill

• 
Relationships with commercial interests:

• 
Grants/Research Support: none

• 
Speakers Bureau/Honoraria: Astra Zeneca, Boehringer Ingelheim, Griffols, Pfizer,
Purdue, Merck Frosst, Novartis, Sanofi, Takeda.

• 
Consulting Fees: Aerocrine, Novartis, Takeda, Purdue, Pfizer

• 
Other:

Member of Health Canada Section on Allergy and Respiratory Therapeutics.

Member of Public Health Agency of Canada section on Respiratory Surveillance
Disclosure of Commercial
Support

• 
This program has received financial support from [none] .

• 
This program has received in-kind support from none in
the form of.

• 
Potential for conflict(s) of interest:

• 
A) there are no organizations supporting this program

• 
B) The following companies make pain management products that we
may mention in this talk including:, Boehringer Ingelheim, Pfizer, Purdue,
Novartis, Sanofi, Takeda, and Janssen Ortho

• 
There are no organizations supporting a product that will be discussed in

this program.
Faculty/Presenter
Disclosure

• 
Faculty: Robert Hauptman BMSc, MD, MCFP

• 
Pain Consultant HealthPoint Clinic

• 
President Elect AMA Chronic Pain Section

• 
Assistant Clinical Professor U of A

• 
Relationships with commercial interests:

• 
Grants/Research Support: none

• 
Speakers Bureau/Honoraria: Astra Zeneca, Boehringer Ingelheim,
Pfizer, Purdue, Merck Frosst, Novartis, Sanofi, Takeda.

• 
Consulting Fees: Janssen, Purdue, Pfizer

• 
Other:

Founding Member Pain Society of Alberta
Disclosure of Commercial
Support

• 
This program has received financial support from [none] .

• 
This program has received in-kind support from none in
the form of.

• 
Potential for conflict(s) of interest:

• 
A) there are no organizations supporting this program

• 
B) The following companies make pain management products that we
may mention in this talk including:, Boehringer Ingelheim, Pfizer, Purdue,
Novartis, Sanofi, Takeda, and Janssen Ortho

• 
There are no organizations supporting a product that will be discussed in

this program.
Mitigating Potential Bias

• 
We will mitigate any bias by discussing appropriately
all treatment and diagnostic options for pain
management in our talk today
Outline

• 
Introduction

• 
Epidemiology of Pain and Addiction

• 
Use, Misuse, Abuse and Addiction

• 
Assessment

• 
Review of Management of CNCP

• 
Case Studies
Introduction
Definition of Pain

An unpleasant sensory and emotional
experience associated with actual or potential
tissue damage, or described in terms of such
damage.1

“Pain is what the patient says it is.” 2
1 Merskey H. Pain. 1979;6:249
2 Canadian Psychological Association. Psychology works for acute postsurgical
pain. http://www.cpa.ca/factsheets/postsurgical.htm Accessed December 21,
2004.
9
Pain

vs.

Suffering�